Concepedia

Author

Elif Birtaş Ateşoğlu

Kocaeli ÜniversitesiORCID

Also Known As

Ateşoğlu, Elif Birtaş, E. Birtaş Ateşoğlu, Elif Birtaş Ateşoğlu, Elif B. Atesoglu, Elif B. Atesoğlu, Elif Birtas ATESOGLU, Elif Birtas Atesoglu, Elif Birtaş ATEŞOĞLU, Elif Birtaş Ateşoğlu, Elif BİRTAŞ ATEŞOĞLU

66

Publications

315

Citations

11

H-Index

35

Concepts

All Affiliations

Kocaeli ÜniversitesiAmerikan HastanesiErciyes UniversityAkdeniz UniversityBaşkent University
EB

About

Elif Birtaş Ateşoğlu is an author at Kocaeli Üniversitesi specializing in medicine, hematology, and pathology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

7

7

114

2

Health Sciences

1

1

10

3

Cellular Therapies

1

1

25

4

Clinical Immunology

1

1

33

5

Hepatology

1

1

10

Elif Birtaş Ateşoğlu

×

12

Publications

209

Citations

10

H-Index

YearCitations

Soluble Programmed Death 1 (PD-1) Is Decreased in Patients With Immune Thrombocytopenia (ITP)

Elif Birtaş Ateşoğlu, Pınar Tarkun, Esra Terzi Demirsoy,

Clinical and Applied Thrombosis/Hemostasis

2014

33

Glofitamab in relapsed/refractory diffuse large B‐cell lymphoma: Real‐world data

Elif Birtaş Ateşoğlu, Zafer Gülbaş, Ant Uzay,

Hematological Oncology

2023

25

Serum hepcidin and growth differentiation factor‐15 (<scp>GDF</scp>‐15) levels in polycythemia vera and essential thrombocythemia

Pınar Tarkun, Özgür Mehtap, Elif Birtaş Ateşoğlu,

European Journal Of Haematology

2013

24

Azacitidine has limited activity in ‘real life’ patients with MDS and AML: a single centre experience

Murat Özbalak, Mustafa Çeti̇ner, Hüseyin Saffet Beköz,

Hematological Oncology

2011

22

Serum Growth Differentiation Factor 15 Levels in Newly Diagnosed Multiple Myeloma Patients

Pınar Tarkun, Elif Birtaş Ateşoğlu, Özgür Mehtap,

Acta Haematologica

2013

19

Brentuximab vedotin consolidation therapy after autologous stem‐cell transplantation in patients with high‐risk Hodgkin lymphoma: Multicenter retrospective study

Olga Meltem Akay, Murat Özbalak, Mustafa Pehlıvan,

Hematological Oncology

2021

19

The Role of β-Catenin in Bcr/Abl Negative Myeloproliferative Neoplasms: An Immunohistochemical Study

Ayfer Gedük, Elif Birtaş Ateşoğlu, Pınar Tarkun,

Clinical Lymphoma Myeloma & Leukemia

2015

13

Dasatinib-induced immune mediated-thrombotic thrombocytopenic purpura

Esra Terzi Demirsoy, Özgür Mehtap, Elif Birtaş Ateşoğlu,

Transfusion and Apheresis Science

2018

12

Blastic Plasmacytoid Dendritic Cell Neoplasm: Skin and Bone Marrow Infiltration of Three Cases and the Review of the Literature

Figen Atalay, Gülşen Tukenmez Demırcı, Dilek Bayramgürler,

Indian Journal of Hematology and Blood Transfusion

2014

11

The role of hepcidin, GDF15, and mitoferrin-1 in iron metabolism of polycythemia vera and essential thrombocytosis patients

Canan ALBAYRAK, Pınar Tarkun, Elif Birtaş Ateşoğlu,

TURKISH JOURNAL OF MEDICAL SCIENCES

2019

11

Page 1